Status:

WITHDRAWN

Prolotherapy for the Treatment of Partial Rotator Cuff Tears

Lead Sponsor:

Hadassah Medical Organization

Conditions:

Rotator Cuff Tear

Eligibility:

All Genders

40-75 years

Phase:

PHASE4

Brief Summary

This is a Prospective Pilot Single Arm study on prolotherapy for the treatment of patients with pain due to Partial Rotator Cuff (RC) Tears of the Shoulder. The aim of this trial is to study the effe...

Detailed Description

Prolotherapy treatments have been used since the 1950s for the treatment of weakened or damaged soft tissue and cartilage. Pre-clinical studies have demonstrated an anabolic response leading to thicke...

Eligibility Criteria

Inclusion

  • With partial rotator cuff tears of either the supraspinatus, infraspinatus or subscapularis tendons of less than 1cm in either length or width
  • With pain lasting more than 6 months
  • Pain with an NRS score of at least 6 out of 10

Exclusion

  • Who had surgical repair, arthroscopy of the affected shoulder
  • With rotator cuff tears larger than 1cm
  • With Rotator cuff arthropathy or osteoarthritis of the glenohumeral joint
  • With primary adhesive capsulitis (frozen shoulder secondary to partial RC tear is not an exclusion criterion)
  • With active malignant disease
  • With fibromyalgia or depression, the latter significant enough to affect their daily life
  • With a history of inflammatory joint disease
  • With localized (to the involved arm) or generalised neuropathic pain
  • With a history of bone fracture within the shoulder girdle which is still causing pain
  • Currently medicated with corticosteroids
  • With active infection
  • Who smoke either tobacco or cannabis
  • Who are pregnant
  • With uncontrolled diabetes
  • Who have any contra-indication to having an MRI scan.
  • Absolute contra-indications to having an MRI scan include any shrapnel in the brain or eye in particular and certain cardiac valves and pacemakers

Key Trial Info

Start Date :

August 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2022

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT04062838

Start Date

August 1 2020

End Date

December 1 2022

Last Update

August 23 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Pain Unit, Hadassah Medical Center

Jerusalem, Israel